Literature DB >> 33894356

The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.

Mengchao Yu1, Jie Lun1, Hongwei Zhang2, Lei Zhu1, Gang Zhang3, Jing Fang4.   

Abstract

The hypoxia-inducible factor (HIF) prolyl hydroxylases (PHDs) are dioxygenases using oxygen and 2-oxoglutarate as co-substrates. Under normoxia, PHDs hydroxylate the conserved prolyl residues of HIFα, leading to HIFα degradation. In hypoxia PHDs are inactivated, which results in HIFα accumulation. The accumulated HIFα enters nucleus and initiates gene transcription. Many studies have shown that PHDs have substrates other than HIFα, implying that they have HIF-independent non-canonical functions. Besides modulating protein stability, the PHDs-mediated prolyl hydroxylation affects protein-protein interaction and protein activity for alternative substrates. Increasing evidence indicates that PHDs also have hydroxylase-independent functions. They influence protein stability, enzyme activity, and protein-protein interaction in a hydroxylase-independent manner. These findings highlight the functional diversity and complexity of PHDs. Due to having inhibitory activity on HIFα, PHDs are proposed to act as tumor suppressors. However, research shows that PHDs exert either tumor-promoting or tumor-suppressing features. Here, we try to summarize the current understanding of PHDs hydroxylase-dependent and -independent functions and their roles in cancer.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Hypoxia-inducible factor; Proline hydroxylation; Prolyl hydroxylase

Year:  2021        PMID: 33894356     DOI: 10.1016/j.biocel.2021.105982

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Novel Compounds as PHD Inhibitors for Treating Heart, Lung, Liver, and Kidney Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-11-04       Impact factor: 4.345

Review 2.  The Role of Hypoxia-Associated Long Non-Coding RNAs in Breast Cancer.

Authors:  Vilma Maldonado; Jorge Melendez-Zajgla
Journal:  Cells       Date:  2022-05-18       Impact factor: 7.666

3.  Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors.

Authors:  Andrey A Poloznikov; Sergey V Nikulin; Dmitry M Hushpulian; Anna Yu Khristichenko; Andrey I Osipyants; Andrey F Asachenko; Olga V Shurupova; Svyatoslav S Savin; Sue H Lee; Irina N Gaisina; Gregory R J Thatcher; Anthony Narciso; Eric P Chang; Sergey V Kazakov; Nancy Krucher; Vladimir I Tishkov; Bobby Thomas; Irina G Gazaryan
Journal:  Antioxidants (Basel)       Date:  2022-01-24

Review 4.  Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor.

Authors:  Na Liu; Rui Ling; Xiang Tang; Yunpeng Yu; Yuepeng Zhou; Deyu Chen
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.